Lisa Quetel

FREQUENT HOMOZYGOUS DELETIONS OF TYPE I INTERFERON GENES IN PLEURAL MESOTHELIOMA CONFER SENSITIVITY TO ONCOLYTIC MEASLES VIRUS.

S. Minvielle, F. Tangy, A. Magnan, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications

J. Zucman‐Rossi, M. Copin, M. Jaurand, 2019, Nature Communications.

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival

S. Imbeaud, J. Zucman‐Rossi, M. Copin, 2020, Molecular oncology.

Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma.

J. Zucman‐Rossi, M. Jaurand, F. Le Pimpec-Barthes, 2018, Lung cancer.

Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma

J. Zucman‐Rossi, M. Jaurand, A. de Reyniès, 2016, Clinical Cancer Research.

Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma

F. Galateau-Sallé, J. Zucman‐Rossi, M. Copin, 2021, Genome medicine.

Abstract 112: Genetic alterations in molecular tumor subgroups of malignant pleural mesothelioma

S. Imbeaud, J. Zucman‐Rossi, M. Jaurand, 2016 .